Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience

Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience

PRINCIPLES: High-dose chemotherapy with subsequent autologous stem cell transplantation (ASCT) is an important treatment option in younger patients with multiple myeloma (MM). We analysed the outcome of patients treated at our institution outside the clinical trials framework and tried to iden...

Full description

Bibliographic Details
Main Authors: P Samaras, M Blickenstorfer, SR Haile, D Siciliano, U Petrausch, A Mischo, M Zweifel, H Honegger, U Schanz, G Stüssi, S Bauer, A Knuth, F Stenner-Liewen
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2011-05-01
Series:Swiss Medical Weekly
Subjects:
autologous stem cell transplantation
multiple myeloma
outcome.
risk factors
Online Access:https://www.smw.ch/index.php/smw/article/view/1295

Internet

https://www.smw.ch/index.php/smw/article/view/1295

Similar Items